Pathogenic Mechanisms of Uropathogens

50.
Reigstad CS, Hultgren SJ, Gordon JI. Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled. J Biol Chem. 2007;282(29):21259–67.CrossRefPubMed
51.
Wright KJ, Seed PC, Hultgren SJ. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol. 2007;9(9):2230–41.CrossRefPubMed
52.
Anderson GG, Goller CC, Justice S, Hultgren SJ, Seed PC. Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis. Infect Immun. 2010;78(3):963–75.PubMedCentralCrossRefPubMed
53.
Goller CC, Seed PC. Revisiting the Escherichia coli polysaccharide capsule as a virulence factor urinary tract infection. Virulence. 2010;1(4):333–7.CrossRefPubMed
54.
Hadjifrangiskou M, Gu AP, Pinkner JS, Kostakioti M, Zhang EW, Greene SE, Hultgren SJ. Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors. J Bacteriol. 2012;194(22):6195–205.PubMedCentralCrossRefPubMed
55.
Blango MG, Mulvey MA. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother. 2010;54(5):1855–63.PubMedCentralCrossRefPubMed
56.
Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun. 2001;69(7):4572–9.PubMedCentralCrossRefPubMed
57.
Mysorekar IU, Hultgren SJ. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A. 2006;103(38):14170–5.PubMedCentralCrossRefPubMed
58.
Gur C, Coppenhagen-Glazer S, Rosenberg S, Yamin R, Enk J, et al. Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells. Cell Host Microbe. 2013;14:664–74.CrossRefPubMed
59.
Dhakal BK, Mulvey MA. The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory and survival pathways. Cell Host Microbe. 2012;11:58–69.PubMedCentralCrossRefPubMed
60.
Wiles TJ, Kulesus RR, Mulvey MA. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol. 2008;85(1):11–9.PubMedCentralCrossRefPubMed
61.
Davis JM, Carvalho HM, Rasmussen SB, O’Brien AD. Cytotoxic necrotizing factor 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis. Infect Immun. 2006;74(8):4401–8.PubMedCentralCrossRefPubMed
Jul 4, 2016 | Posted by in UROLOGY | Comments Off on Pathogenic Mechanisms of Uropathogens

Full access? Get Clinical Tree

Get Clinical Tree app for offline access